KASINGER JAMES R. (General Counsel and Secretary) sold 1.1% of their position (1.04K shares) of CRISPR THERAPEUTICS AG on the open market
Open‑market sale worth $51.2K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 10/15/2026ACC: 0001193125-26-423057
Officer· General Counsel and Secretary
Since Feb 2026
-1.04K
Net shares
Net seller
$51.2K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
2.11K acquired · 3.15K disposed
Non-Derivative Transactions2
Common Shares
Direct
Shares
+2.11K
Price / share
—
Trade value
—
% of position
2.2%
10/13/2026
94.78K→96.90K
Common Shares
Direct
Shares
−1.04K
Price / share
$49.26
Trade value
$51.23K
% of position
1.1%
10/14/2026
96.90K→95.86K
Total
Net shares
+1.07K
Net value
-$51.23K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Shares Direct | 10/13/2026 | M · Option Exercise | +2.11K | — | — | 2.2% | 94.78K | 96.90K |
| Common Shares Direct | 10/14/2026 | S · Sale | −1.04K | $49.26 | $51.23K | 1.1% | 96.90K | 95.86K |
| Total | +1.07K | -$51.23K | ||||||
Derivative Transactions1
Restricted Stock Units
Direct
Converts to
Common Shares
2.11K shares
Shares
−2.11K
Strike price
Held after
0.00
Exercisable
—
10/13/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Units Direct | Common Shares2.11K shares | 10/13/2026 | M · Option Exercise | −2.11K | — | 0.00 |